Profitability Ratios
| Ratio |
Value |
| GP Margin |
89.3% |
| EBIT Margin |
-3270.9% |
| EBITDA Margin |
-3260.1% |
| Operating Margin |
-3270.9% |
| Pretax Margin |
-1046.4% |
| Cont. Ops Margin |
-1046.4% |
| Net Margin |
-1046.4% |
| Bottom Line Margin |
-1046.4% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
14.50 |
| Quick Ratio |
14.50 |
| Solvency Ratio |
-2.064 |
| Cash Ratio |
7.43 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
0.04 |
| Forward PEG |
0.04 |
| Price/Book |
0.53 |
| Price/Sales |
36.02 |
| Price/FCF |
-1.04 |
| Price/Op Cash Flow |
-1.04 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.0028 |
| Debt/Equity |
0.0030 |
| Debt/Capital |
0.0030 |
| Long-Term Debt/Capital |
0.0014 |
| Financial Leverage |
1.07 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
0.01 |
| Operating Cash Flow Ratio |
-7.060 |
| Operating Cash Flow/Sales |
-3474.7% |
| Free Cash Flow/Operating Cash Flow |
100.0% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
-297.57 |
| Interest Coverage |
0.0000 |
| Short-Term Operating Cash Flow Coverage |
-317.16 |
| Operating Cash Flow Coverage |
-169.39 |
| Capital Expenditure Coverage |
0.00 |
| Dividend + Capital Expenditure Coverage |
0.00 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
0.15 |
| EPS |
-1.595 |
| Debt/Share |
0.0313 |
| Cash/Share |
9.72 |
| Book Value/Share |
10.30 |
| Tangible BV/Share |
10.30 |
| Equity/Share |
10.30 |
| Operating Cash Flow/Share |
-5.296 |
| Capital Expenditure/Share |
0.000 |
| FCF/Share |
-5.296 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
1.000 |
| Earnings Before Tax/EBIT |
0.320 |
| Price/Fair Value |
0.53 |
| Debt/Market Cap |
0.0057 |
| Effective Tax Rate |
0.0% |
| Enterprise Value Multiple |
0.01 |
RLYB - Rallybio Corporation